Yet no actual white papers or ever working for or consulting for any biotech or big pharma prior to getting paid 117k by his brother. Unlike the other SAB members who got shares, Brian wanted cash up front because he knows shares in rgbp are worthless.
Market Data 
Markets 
AI
